tiprankstipranks
Advertisement
Advertisement

HK:2595 Stock Latest News

GenFleet Advances Second Phase III Trial for Oral KRAS G12D Lung Cancer Drug
Company AnnouncementsGenFleet Advances Second Phase III Trial for Oral KRAS G12D Lung Cancer Drug
8d ago
2595
GenFleet Therapeutics Schedules Board Meeting to Review Interim Results and Dividend
PremiumCompany Announcements
GenFleet Therapeutics Schedules Board Meeting to Review Interim Results and Dividend
12d ago
2595
GenFleet Therapeutics Raises HK$471.8 Million Through H-Share Placing
PremiumCompany Announcements
GenFleet Therapeutics Raises HK$471.8 Million Through H-Share Placing
1M ago
2595
Genfleet Therapeutics Plans HK$471.8 Million H‑Share Placing Under General Mandate
PremiumCompany Announcements
Genfleet Therapeutics Plans HK$471.8 Million H‑Share Placing Under General Mandate
1M ago
2595
GenFleet Therapeutics to Launch HK$350 Million H-Share Buyback
PremiumCompany Announcements
GenFleet Therapeutics to Launch HK$350 Million H-Share Buyback
2M ago
2595
GenFleet’s KRAS G12D Inhibitor Shows Early Efficacy in Cholangiocarcinoma and Colorectal Cancer
PremiumCompany AnnouncementsGenFleet’s KRAS G12D Inhibitor Shows Early Efficacy in Cholangiocarcinoma and Colorectal Cancer
3M ago
2595
GenFleet’s First-in-Class Cachexia Antibody Shows Promising Phase I Data at ASCO
Premium
Company Announcements
GenFleet’s First-in-Class Cachexia Antibody Shows Promising Phase I Data at ASCO
3M ago
2595
GenFleet Shareholders Back All Resolutions at 2026 Annual General Meeting
Premium
Company Announcements
GenFleet Shareholders Back All Resolutions at 2026 Annual General Meeting
3M ago
2595
GenFleet Asserts Independent IP for Pan RAS Inhibitor GFH276 Amid Sector Dispute
PremiumCompany Announcements
GenFleet Asserts Independent IP for Pan RAS Inhibitor GFH276 Amid Sector Dispute
4M ago
2595
GenFleet Therapeutics Sets 2025 AGM to Seek Mandates on Governance and Share Capital
PremiumCompany Announcements
GenFleet Therapeutics Sets 2025 AGM to Seek Mandates on Governance and Share Capital
4M ago
2595
GenFleet’s KRAS G12D Drug Wins Second Breakthrough Tag as First Pancreatic Cancer Monotherapy in China
PremiumCompany Announcements
GenFleet’s KRAS G12D Drug Wins Second Breakthrough Tag as First Pancreatic Cancer Monotherapy in China
4M ago
2595
GenFleet Tightens Audit Committee Charter to Bolster Governance
PremiumCompany Announcements
GenFleet Tightens Audit Committee Charter to Bolster Governance
5M ago
2595
GenFleet Tightens Remuneration Committee Mandate to Bolster Governance
PremiumCompany AnnouncementsGenFleet Tightens Remuneration Committee Mandate to Bolster Governance
5M ago
2595
GenFleet Tightens Board Nomination Rules to Strengthen Governance
Premium
Company Announcements
GenFleet Tightens Board Nomination Rules to Strengthen Governance
5M ago
2595
GenFleet Therapeutics Narrows Adjusted Loss and Bolsters Cash as 2025 Results Released
Premium
Company Announcements
GenFleet Therapeutics Narrows Adjusted Loss and Bolsters Cash as 2025 Results Released
5M ago
2595
GenFleet to Showcase RAS-Targeted Preclinical Data at 2026 AACR Meeting
PremiumCompany Announcements
GenFleet to Showcase RAS-Targeted Preclinical Data at 2026 AACR Meeting
5M ago
2595
GenFleet Therapeutics Sets March Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
GenFleet Therapeutics Sets March Board Meeting to Approve 2025 Results and Consider Dividend
5M ago
2595
GenFleet Therapeutics to Join Stock Connect and Key Hang Seng Indexes in 2026
PremiumCompany Announcements
GenFleet Therapeutics to Join Stock Connect and Key Hang Seng Indexes in 2026
5M ago
2595
GenFleet Wins China Breakthrough Therapy Nod for KRAS G12D Lung Cancer Drug
PremiumCompany Announcements
GenFleet Wins China Breakthrough Therapy Nod for KRAS G12D Lung Cancer Drug
6M ago
2595
GenFleet Added to Hang Seng and MSCI Indexes, Boosting Market Profile
PremiumCompany AnnouncementsGenFleet Added to Hang Seng and MSCI Indexes, Boosting Market Profile
6M ago
2595
GenFleet Shareholders Approve Incentive Schemes and Governance Overhaul at EGM
Premium
Company Announcements
GenFleet Shareholders Approve Incentive Schemes and Governance Overhaul at EGM
6M ago
2595
GenFleet Therapeutics Calls EGM to Approve New H-Share Incentive Plans, Buy-back Mandate and Governance Changes
Premium
Company Announcements
GenFleet Therapeutics Calls EGM to Approve New H-Share Incentive Plans, Buy-back Mandate and Governance Changes
7M ago
2595

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >